Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« The Search for Emotional Truth | Main | Milton Friedman Nobel Economist Passes On at 94 »

November 14, 2006

Top Ten Reasons For Personalized Medicine

Email This Entry

Posted by Zack Lynch

I just spent the past two days at a Personalized Medicine conference sponsored by Burrill and the Personalized Medicine Coalition. Among the many interesting sessions, dominated by diagnostic company CEOs, Ed Abrahams, the PMC's Executive Director gave a talk that covered the top 10 value propositions for supporting and promoting personalized medicine. Advocates of personalized medicine have stressed its potential to:

1) Detect disease at an earlier stage, when it is easier to treat effectively
2) Enable the selection of optimal therapy and reduce trial-and-error prescribing
3) Reduce adverse drug reactions
4) Increase patient compliance with therapy
5) Improve the selection of targets for drug discovery
6) Reduce the time, cost, and failure rate of clinical trials
7) Revive drugs that failed clinical trials or were withdrawn from the market
8) Avoid withdrawal of marketed drugs
9) Shift the emphasis in medicine from reaction to prevention
10) Reduce the overall cost of healthcare

Logo_PersMed_06.gifSeems like a list we could all agree would be great to have. To support his presentation, the PMC published a pithy primer on the topic of personalized medicine which I recommend. (Download report here). As an aside, from my conversations it looks interest in developing diagnostics for neurological diseases is on the rise, but still far behind the developments in oncology.

Comments (3) + TrackBacks (0) | Category: NIO


COMMENTS

1. Kensai on November 15, 2006 4:43 PM writes...

If I understood correctly, Personalized Medicine is a more holistic approach of "pharmacogenetics". Taking into account various factors (both internal and external) to deduce the best therapy.

Constantine

Permalink to Comment

2. Martijn Arns on February 27, 2007 3:44 PM writes...

Personalized Medicine is indeed a great new nd exciting development for the future. We have quite a lot of experience with that as well, reviewing many individual Brain Profiles using QEEG and neuropsychology. In this way it becomes very evident that disorders such as ADHD or depression do not show a uniform deviating brain profile. For more info also see on www.qeeg.nl under Personalized Medicine a very informative section on ADHD and Depression.

Martijn Arns
Brain Resource Company B.V.
The Netherlands

Permalink to Comment

3. Martijn Arns on July 9, 2007 5:24 PM writes...

We just changed our website to www.brainclinics.com
For more information on Personalized Medicine also see www.personalized-medicine.eu

Permalink to Comment

POST A COMMENT

Thanks for signing in, . Now you can comment. (sign out)

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)





Remember me?


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives